Skip to main content
SpringerLink
Log in

Primary prevention is important in reducing the incidence of toxoplasmosis

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Van Voorhis WC. Therapy and prophylaxis of systemic protozoan infections. Drugs 1990; 40(2): 176–202

    Article  PubMed  Google Scholar 

  2. St Georgiev V. Management of toxoplasmosis. Drugs 1994 Aug; 48(2): 179–88

    Article  Google Scholar 

  3. Stray-Pedersen B. Treatment of toxoplasmosis in the pregnant mother and newborn child. In: Congenital toxoplasmosis. Lebech M, Petersen E, editors. Scand J Infect Dis 1992; Suppl. 84; 23–31

  4. Murray HW. Toxoplasmosis. In: Wilson JD, et al., editors. Harrison’s principles of internal medicine, 12th ed. New York: McGraw-Hill, 1991: 795–9

    Google Scholar 

  5. Foulon W. Congenital toxoplasmosis: is screening desirable? In: Congenital toxoplasmosis. Lebech M, Petersen E, editors. Scand J Infect Dis 1992; Suppl. 84; 11–7

  6. Stray-Pedersen B, Jenum P. Economic evaluation of preventive programmes against congenital toxoplasmosis. In: Congenital toxoplasmosis. Lebech M, Petersen E, editors. Scand J Infect Dis 1992; Suppl. 84; 86–96

  7. Guerina NG, Hsu H-W, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. New Engl J Med 1994 Jun 30; 330: 1858–63

    Article  PubMed  CAS  Google Scholar 

  8. Katlama C. New perspectives on the treatment and prophylaxis of Toxoplasma gondii infection. Curr Opin Infect Dis 1992; 5: 833–9

    Article  Google Scholar 

  9. Jacobson MA, Besch CL, Child C, et al. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. J Infect Dis 1994 Feb; 169: 384–94

    Article  PubMed  CAS  Google Scholar 

  10. Opravil M, Hirschel B, Lazzarin A, et al. Once weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis 1995 Mar; 20: 531–41

    Article  PubMed  CAS  Google Scholar 

  11. Podzamczer D, Salazar A, Jiménez J, et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995 May 15; 122: 755–61

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Primary prevention is important in reducing the incidence of toxoplasmosis. Drugs Ther. Perspect 6, 9–12 (1995). https://doi.org/10.2165/00042310-199506050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199506050-00004

Keywords

Search

Navigation